Showing results (281-290 of 305) with videos related to

Sort By:
Pageof 31
Cancer Research|September 5, 2019
Heparanase Accelerates Obesity-Associated Breast Cancer ProgressionEsther Hermano, Rachel Goldberg, Ariel M Rubinstein, et al.
Cancer Letters|December 12, 2017
Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastasesGiuliana Cassinelli, Laura Dal Bo, Enrica Favini, et al.
Seminars in Thrombosis and Hemostasis|July 17, 2007
O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasisMarjut Borgenström, Anni Wärri, Katri Hiilesvuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axisJoseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, et al.
Scientific Reports|December 15, 2015
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer CellsMoshe Giladi, Rosa S Schneiderman, Tali Voloshin, et al.
Biology of Reproduction|February 25, 2005
Spatiotemporal expression of heparanase during human and rodent ovarian folliculogenesisRonit Haimov-Kochman, Diana Prus, Eyal Zcharia, et al.
ACS Chemical Biology|November 28, 2018
Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer TherapyOlga V Zubkova, Yassir A Ahmed, Scott E Guimond, et al.
Diabetes|November 23, 2011
Heparanase is essential for the development of diabetic nephropathy in miceNatali Gil, Rachel Goldberg, Tzahi Neuman, et al.
The Journal of Clinical Investigation|October 8, 2009
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinomaAndreas Bonertz, Jürgen Weitz, Dong-Ho Kim Pietsch, et al.
Pageof 31